Afriflu2-Second international workshop on influenza vaccination in the African continent-8 November 2012, Cape Town (South Africa)

Vaccine

Volumn 31, Issue 35, 2013, Pages 3461-3466

  Schoub, Barry D ^a   Gessner, Bradford D ^b   Ampofo, William ^c   Cohen, Adam L ^d   Steffen, Christoph A ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b Agence de Médecine Préventive AMP   (France)

^c University of Ghana   (Ghana)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Africa; Conference report; Illness burden; Influenza; Priority groups; Vaccine security; Vaccines

Indexed keywords

INFLUENZA VACCINE;

AFRICAN FLU; COMPARATIVE STUDY; CONFERENCE PAPER; DEVELOPING COUNTRY; DRUG EFFICACY; DRUG SAFETY; HEALTH CARE PERSONNEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNIZATION; INFLUENZA; INFLUENZA VACCINATION; LOWER RESPIRATORY TRACT INFECTION; MIXED INFECTION; MORTALITY; OCCUPATIONAL HAZARD; PANDEMIC; PREGNANT WOMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT DISEASE; SEASONAL INFLUENZA; SOUTH AFRICA; STREPTOCOCCUS PNEUMONIAE; TUBERCULOSIS; VACCINE PRODUCTION; WORLD HEALTH ORGANIZATION;

AFRICA; CONFERENCE REPORT; DCVMN; DEVELOPING COUNTRIES VACCINE MANUFACTURERS NETWORK; ILI; ILLNESS BURDEN; INFLUENZA; INFLUENZA-LIKE ILLNESS; LAIV; LIVE-ATTENUATED INFLUENZA VACCINE; PRIORITY GROUPS; SAGE; SARI; SEVERE ACUTE RESPIRATORY ILLNESS; STRATEGIC ADVISORY GROUP OF EXPERTS ON IMMUNISATION; TIV; TRIVALENT INACTIVATED INFLUENZA VACCINE; VACCINE SECURITY; VACCINES; WHO; WORLD HEALTH ORGANIZATION;

AFRICA; COINFECTION; EPIDEMIOLOGICAL MONITORING; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; VACCINATION;

EID: 84880718527     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.04.021     Document Type: Conference Paper

References (37)

1. Steffen C., Diop O.M., Gessner B.D., Hacen M.M., Hassar M., Katz M.A., et al. Afriflu - international conference on influenza disease burden in Africa, 1-2 June 2010, Marrakech, Morocco. Vaccine 2010, 29(3):363-369.
2. Radin J.M., Katz M.A., Tempia S., Talla Nzussouo N., Davis R., Duque J., et al. Influenza surveillance in 15 countries in Africa, 2006-2010. J Infect Dis 2012, 206(Suppl. 1):S14-S21.
3. Katz M.A., Schoub B.D., Heraud J.M., Breiman R.F., Njenga M.K., Widdowson M.A. Influenza in Africa: uncovering the epidemiology of a long-overlooked disease. J Infect Dis 2012, 206(Suppl. 1):S1-S4.
4. 3rd annual African network for influenza surveillance and epidemiology (ANISE) meeting February 1-3, 2012.
5. Cohen C., Simonsen L., Kang J.W., Miller M., McAnerney J., Blumberg L., et al. Elevated influenza-related excess mortality in South African elderly individuals, 1998-2005. Clin Infect Dis 2010, 51(12):1362-1369.
6. Berkley J.A., Munywoki P., Ngama M., Kazungu S., Abwao J., Bett A., et al. Viral etiology of severe pneumonia among Kenyan infants and children. JAMA 2010, 303(20):2051-2057.
7. Feikin D.R., Ope M.O., Aura B., Fuller J.A., Gikunju S., Vulule J., et al. The population-based burden of influenza-associated hospitalization in rural western Kenya, 2007-2009. Bull World Health Organ 2012, 90(4). 256-63A.
8. Katz M.A., Lebo E., Emukule G., Njuguna H.N., Aura B., Cosmas L., et al. Epidemiology, seasonality, and burden of influenza and influenza-like illness in urban and rural kenya, 2007-2010. J Infect Dis 2012, 206(Suppl. 1):S53-S60.
9. Njouom R., Yekwa E.L., Cappy P., Vabret A., Boisier P., Rousset D. Viral etiology of influenza-like illnesses in cameroon, January-December 2009. J Infect Dis 2012, 206(Suppl. 1):S29-S35.
10. Bonney J.H., Kronmann K.C., Lindan C.P., Asante I.A., Parbie P., Aboagye J., et al. Virological surveillance of influenza-like illness among children in Ghana, 2008-2010. J Infect Dis 2012, 206(Suppl. 1):S108-S113.
11. Cohen C., Simonsen L., Sample J., Kang J.W., Miller M., Madhi S.A., et al. Influenza-related mortality among adults aged 25-54years with AIDS in South Africa and the United States of America. Clin Infect Dis 2012, 55(7):996-1003.
12. Walaza S., Malope-Kgokong M.J., Groome B., Tempia M., Dawood S., Cohen H., et al. Risk of death amongst TB patients hospitalized with influenza in South Africa, 2009-2010. 3rd annual African network for influenza surveillance and epidemiology (ANISE) meeting February 1-3 2012.
13. Wolter N., Tempia C.C., Du Plessis S., Groome M., Moyes M., Walaza J., et al. Increased risk of pneumococcal pneumonia among HIV and influenza co-infected patients hospitalized with pneumonia in South Africa, 2009-2010. 3rd annual African network for influenza surveillance and epidemiology (ANISE) meeting February 1-3, 2012.
14. Garg S., SanJoaquin E.D., Anderson M., Mallewa S., Rothe J., Katakngwe C., et al. Seasonality and burden of influenza among children and adults presenting to Queen Elizabeth Central Hospital with influenza-like illness or severe acute respiratory illness - Blantyre, Malawi, January-September 2011. 3rd annual African network for influenza surveillance and epidemiology (ANISE) meeting February 1-3, 2012.
15. Ope M.O., Katz M.A., Aura B., Gikunju S., Njenga M.K., Ng'ang'a Z., et al. Risk factors for hospitalized seasonal influenza in rural western Kenya. PLoS One 2011, 6(5):e20111.
16. McAnerney J.M., Cohen C., Moyes J., Besselaar T.G., Buys A., Schoub B.D., et al. Twenty-five Years of Outpatient Influenza Surveillance in South Africa, 1984-2008. J Infect Dis 2012, 206(Suppl. 1):S153-S158.
17. Theo A., Liwewe M., Ndumba I., Mupila Z., Tambatamba B., Mutemba C., et al. Influenza surveillance in zambia, 2008-2009. J Infect Dis 2012, 206(Suppl. 1):S173-S177.
18. Cardoso Y., Oliveira E., Vasconcelos J., Cohen A.L., Francisco M. Characteristics of patients with influenza-like illness, severe acture respiratory illness, and laboratory-confirmed influenza at a major children's hospital in Angola, 2009-2011. J Infect Dis 2012, 206(Suppl. 1):S136-S139.
19. Muyembe Tamfum J.J., Nkwembe E., Bi Shamamba S.K., Bankoshi F., Ilunga B.K., Katz K.A., et al. Sentinel surveillance for influenza-like illness, severe acute respiratory illness, and laboratory-confirmed influenza in Kinshasa, democratic republic of Congo, 2009-2011. J Infect Dis 2012, 206(Suppl. 1):S36-S40.
20. World Health Organization Meeting of the strategic advisory group of experts on immunization, November 2011 - conclusions and recommendations. Wkly Epidemiol Rec 2012, 201-208.
21. Neuzil K.M., Reed G.W., Mitchel E.F., Simonsen L., Griffin M.R. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol 1998, 148(11):1094-1102.
22. Archer B., Cohen C., Naidoo D., Thomas J., Makunga C., Blumberg L., et al. Interim report on pandemic H1N1 influenza virus infections in South Africa, April-October 2009: epidemiology and factors associated with fatal cases. Euro Surveill 2009, 14(42).
23. Steinhoff M.C., Omer S.B., Roy E., El Arifeen S., Raqib R., Dodd C., et al. Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial. CMAJ 2012, 184(6):645-653.
24. Zaman K., Roy E., Arifeen S.E., Rahman M., Raqib R., Wilson E., et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008, 359(15):1555-1564.
25. Omer S.B., Goodman D., Steinhoff M.C., Rochat R., Klugman K.P., Stoll B.J., et al. Maternal influenza immunization and reduced likelihood of prematurity and small for gestational age births: a retrospective cohort study. PLoS Med 2011, 8(5):e1000441.
26. Nair H., Brooks W.A., Katz M., Roca A., Berkley J.A., Madhi S.A., et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet 2011, 378(9807):1917-1930.
27. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289(2):179-186.
28. Health Systems Trust SA health review 2011 2011.
29. Madhi S.A., Schoub B., Simmank K., Blackburn N., Klugman K.P. Increased burden of respiratory viral associated severe lower respiratory tract infections in children infected with human immunodeficiency virus type-1. J Pediatr 2000, 137(1):78-84.
30. Madhi S.A., Maskew M., Koen A., Kuwanda L., Besselaar T.G., Naidoo D., et al. Trivalent inactivated influenza vaccine in African adults infected with human immunodeficient virus: double blind, randomized clinical trial of efficacy, immunogenicity, and safety. Clin Infect Dis 2011, 52(1):128-137.
31. Madhi S.A., Dittmer S., Kuwanda L., Venter M., Cassim H., Lazarus E., et al. Efficacy and immunogenicity of influenza vaccine in HIV-infected children: a randomized, double-blind, placebo controlled trial. AIDS 2013, 27:369-379.
32. van Vuuren A., Rheeder P., Hak E. Effectiveness of influenza vaccination in the elderly in South Africa. Epidemiol Infect 2009, 137(7):994-1002.
33. World Health Organization Global pandemic influenza action plan to increase vaccine supply 2006.
34. Rhorer J., Ambrose C.S., Dickinson S., Hamilton H., Oleka N.A., Malinoski F.J., et al. Efficacy of live attenuated influenza vaccine in children: a meta-analysis of nine randomized clinical trials. Vaccine 2009, 27(7):1101-1110.
35. Neuzil K.M., Tsvetnitsky V., Nyari L.J., Bright R.A., Boslego J.W. PATH Influenza Vaccine Project: accelerating the development of new influenza vaccines for low-resource countries. Expert Rev Vaccines 2012, 11(8):939-947.
36. Vesikari T., Knuf M., Wutzler P., Karvonen A., Kieninger-Baum D., Schmitt H.J., et al. Oil-in-water emulsion adjuvant with influenza vaccine in young children. N Engl J Med 2011, 365(15):1406-1416.
37. Belshe R.B., Edwards K.M., Vesikari T., Black S.V., Walker R.E., Hultquist M., et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007, 356(7):685-696.